Showing results (1-10 of 141) with videos related to
Sort By:
Pageof 15
Neuropeptides|November 1, 1988
Effects of intracerebroventricularly administered somatostatin on passive avoidance, shuttle-box behaviour and open-field activity in ratsL Vécsei, E WiderlövOrvosi Hetilap|February 9, 1997
[Neurodegeneration: aging and dementia. Etiopathogenic role of electron transport disorders. Therapeutic possibilities]P Klivényi, L VécseiOrvosi Hetilap|January 5, 2002
[Clinical symptoms, diagnosis and treatment of focal dystonias]P Klivényi, L VécseiOrvosi Hetilap|July 19, 1992
[Kynurenine and its metabolites in nervous system diseases]L Vécsei, F SchwabOrvosi Hetilap|August 1, 1993
[Current data on the pathogenesis of neurodegenerative diseases and some muscular disorders: therapeutic prospectives]L Vécsei, E PálInternational Journal of Clinical Pharmacology and Therapeutics|September 30, 2010
Medical treatment of Parkinson's disease: today and the futureG Gárdián, L VécseiArchives of Gerontology and Geriatrics|July 1, 1995
Somatostatin and Alzheimer's diseaseL Vécsei, P KlivényiProgress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1990
Preclinical and clinical studies with cysteamine and pantethine related to the central nervous systemL Vécsei, E WiderlövJournal of Neural Transmission (Vienna, Austria : 1996)|October 14, 2004
Huntington's disease: pathomechanism and therapeutic perspectivesG Gárdián, L VécseiPsychoneuroendocrinology|January 1, 1990
Effects of somatostatin-28 and some of its fragments and analogs on open-field behavior, barrel rotation, and shuttle box learning in ratsL Vécsei, E WiderlövPageof 15